DK Life Science Co., Ltd. (303810.KQ) stock: key figures, P/E, revenue and dividend
Health Care · South Korea
DK Life Science Co., Ltd. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 131.82 bn KRW | 130.34 bn KRW |
| Gross profit | 28.59 bn KRW | 33.00 bn KRW |
| Operating income | 11.92 bn KRW | 13.05 bn KRW |
| EBIT | 12.74 bn KRW | 14.60 bn KRW |
| Net income | 2.24 bn KRW | 8.66 bn KRW |
| Diluted EPS – continuing operations | 70.18 KRW | 270.70 KRW |
Full history since 2022, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About DK Life Science Co., Ltd.
DK Life Science Co., Ltd., a pharmaceutical company, develops and sells diagnostic medicines and medical devices in South Korea and internationally. It offers active pharmaceutical ingredients (API), injections, blood glucose self-monitoring device, Mobile CT equipment, and ultrasonic instruments. The company also offers catheters, MRI, CT scanner, ultrasound, mobile CT scanner, and X-ray equipment, as well as mammography image analysis assistance software. DK Life Science Co., Ltd. was founded in 2017 and is based in Seoul, South Korea.
More stocks
- Innometry Co. Ltd (302430.KQ)
- Forward Science Corp. (7530.TWO)
- PPI Inc (062970.KQ)
- FRANKLIN STREET PROPERTIES CORP /MA/ (FSP)
- Bunker Hill Mining Corp. (BHLL)
- M2I Corporation (347890.KQ)
- Technology & Telecommunication Acquisition Corp (TETEF)
- Masisa (MASISA.SN)
- SOLITARIO RESOURCES CORP. (XPL)
- Datasolution, Inc. (263800.KQ)
- QUAINT OAK BANCORP, INC. (QNTO)
- GameSquare Holdings, Inc. (GAME)
Not investment advice. All data without warranty, price as of 16.11.2026. Details in the risk notice.